House panel calls to ban China trial data from FDA drug trial applications
A powerful spending committee in Congress wants the FDA to ban the use of clinical trial data from China in future applications by drugmakers to test new drugs. The language was
ORIGINAL SOURCE →via Endpoint News
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · CN
- [HEALTH] Who writes the pandemic? State power, individual subjectivity, and the history of the present in China's COVID-19 respon
- [CYBER] Chinese hackers vulnerable to U.S. arrest if they travel, FBI official says
- [CYBER] FBI cyber boss: China's hacker-for-hire ecosystem 'out of control'
- [HEALTH] China's brain-control weapons race being led by Harvard scientist who was jailed in US
- [AVIATION] I visited the county archives and pored over this book, which was sent to Chiang, FDR, Churchill, Stalin, and De Gaulle.…
- [CONFLICT] FDI rule tweak for China-linked firms awaited